Results 131 to 140 of about 58,368 (237)

B Cell Subsets and Atherosclerosis: Updates and Emerging Concepts

Immunological Reviews, Volume 339, Issue 1, May 2026.
ABSTRACT Atherosclerotic cardiovascular disease (ASCVD) is increasingly recognized not just as a lipid‐driven disease, but as a complex interplay between vascular cells and the immune system. Accumulating evidence highlights a central, yet heterogeneous role for B cells in atherogenesis, with distinct subsets displaying opposing roles.
Sophieke Lems, Megan Grace Mazzei, Amanda C. Foks, Coleen A. McNamara   +3 more
wiley   +1 more source

Serum CTRP3 and CysC correlate with glucose, lipid, and bone metabolism in elderly patients with type 2 diabetes mellitus complicated with osteoporosis

Journal of Diabetes Investigation, Volume 17, Issue 5, Page 880-891, May 2026.
Serum levels of CTRP3 and CysC in elderly patients with T2DM and OP are closely associated with glucose‐lipid metabolism, bone mineral density, and bone metabolism markers. Combined detection of these two markers can assist in distinguishing OP in elderly patients with T2DM.
Yi‐Peng Wang, Yong Wang, Tao Chen, Gang Chen, Ze‐Yu Yang   +4 more
wiley   +1 more source

Blockade of Complement Cell Lysis and C3d Fixation by Patient HLA‐A1 Antibodies: Towards a New Therapy for Prevention of Antibody‐Mediated Rejection

HLA, Volume 107, Issue 5, May 2026.
ABSTRACT Donor‐specific HLA antibodies (DSA) occurring prior to or appearing de novo after transplantation play a major role in kidney graft loss, mainly caused by complement activation by DSA. As potential therapeutics, immunologically inert human monoclonal antibodies (mAbs) preventing binding of DSA to HLA‐A1 molecules would limit their detrimental ...
Tineke Kardol‐Hoefnagel, Dilara Akharman‐Oztoprak, Els van der Meijden, Frans H. Claas, Frank J. Beurskens, Henny G. Otten   +5 more
wiley   +1 more source

Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab

Терапевтический архив, 2013
AIM: To determine the time course of changes in the blood levels of antibodies (Ab) to complement component C1q (a-C1q) in patients with systemic lupus erythematosus (SLE) during rituximab (RTM) therapy and the association with organ injuries in SLE ...
M É Tsanian, A V Torgashina, E N Aleksandrova, S K Solov'ev, E L Nasonov   +4 more
doaj  

Clinical utility and performance of anti-C1q antibodies for SLE: comparative analysis of three different assays. [PDF]

Lupus Sci Med
Gonzalez-Treviño M, Hetrick MD, Sanchez-Rodriguez A, Duarte-Garcia A, Tebo AE.   +4 more
europepmc   +1 more source

Macrophage metabolic exhaustion and PANoptotic cell death drive chronic tissue inflammation in rheumatoid arthritis. [PDF]

Immunity
Huang T, Takashima Y, Kumar J, Morales J, Le K, Hu Z, Rubino S, Trousdale RT, Berry GJ, Goronzy JJ, Weyand CM.   +10 more
europepmc   +1 more source

APOE-mediated lipid transport prevents C1q-related synaptic loss after spinal cord injury via attenuating macrophage lipid stress. [PDF]

J Neuroinflammation
Mulat Y, Ren Z, Nong C, Fu C, Huo Y, Zhao M, Dai Y, Chen C, Wang P, Wang R, Zhang H, Hu Y, Lai P, Guo R, Jiang D, Peng Y, Lin H.   +16 more
europepmc   +1 more source

Divergence of C4A and C4B in first-episode psychosis: Insights from CSF and plasma immune profiling. [PDF]

Transl Psychiatry
Arjmand S, Chaudhary M, Samudyata, Piehl F, Pelanis A, Engberg G, Cervenka S, Landén M, Erhardt S, Sellgren CM.   +9 more
europepmc   +1 more source

C1q Deficiency [PDF]

, 2020
openaire   +1 more source

Childhood-onset hypocomplementaemic urticarial vasculitis in France: phenotypic and genotypic diversity in 10 children. [PDF]

Pediatr Rheumatol Online J
Bianchi C, Melki I, Sisirak V, Loizon S, Broly M, Boursier G, Tusseau M, Laurent A, Belot A, Eitenschenck L, Guigonis V, Jeziorski E, Leguevaques D, Richer O, Pillet P, Granel J.   +15 more
europepmc   +1 more source